Medpacto Adopts Additional Multiple Myeloma Combined Clinical Trials at ASCO

Medpacto Adopts Additional Multiple Myeloma Combined Clinical Trials at ASCO Release of data on phase 1b clinical trial for combination therapy with multiple myeloma, a blood cancer [April 14, 2021] Medpacto (CEO Seong-Jin Kim) announced on the 14th that one additional clinical data for combination therapy with Vactosertib submitted to the annual meeting of the American Society of Clinical Oncology (ASCO) has been adopted as the subject of the presentation. On the 6th, Medpacto announced that the data for phase 1b·2a of a combination clinical trial of Vactosertib and Keytruda for colorectal ca..........

원문링크 : Medpacto Adopts Additional Multiple Myeloma Combined Clinical Trials at ASCO